1. Home
  2. ASMB vs TMQ Comparison

ASMB vs TMQ Comparison

Compare ASMB & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$33.62

Market Cap

553.6M

Sector

Health Care

ML Signal

HOLD

Logo Trilogy Metals Inc.

TMQ

Trilogy Metals Inc.

HOLD

Current Price

$4.59

Market Cap

785.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
TMQ
Founded
2005
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
553.6M
785.2M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
ASMB
TMQ
Price
$33.62
$4.59
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$43.40
N/A
AVG Volume (30 Days)
146.3K
3.2M
Earning Date
11-10-2025
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,191,000.00
N/A
Revenue This Year
$33.33
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
31.30
N/A
52 Week Low
$7.75
$1.06
52 Week High
$39.71
$11.29

Technical Indicators

Market Signals
Indicator
ASMB
TMQ
Relative Strength Index (RSI) 48.44 51.95
Support Level $31.73 $4.23
Resistance Level $33.97 $4.96
Average True Range (ATR) 2.08 0.30
MACD -0.21 -0.03
Stochastic Oscillator 28.21 48.63

Price Performance

Historical Comparison
ASMB
TMQ

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About TMQ Trilogy Metals Inc.

Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.

Share on Social Networks: